Elicio Therapeutics Inc (ELTX)
8.17
-0.32
(-3.77%)
USD |
NASDAQ |
Jun 14, 16:00
8.03
-0.14
(-1.71%)
After-Hours: 20:00
Elicio Therapeutics Net Income (Quarterly): -11.83M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -11.83M |
| December 31, 2023 | -8.949M |
| September 30, 2023 | -10.66M |
| June 30, 2023 | -7.559M |
| March 31, 2023 | -8.029M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.651M |
| September 30, 2022 | -7.198M |
| June 30, 2022 | -7.299M |
| March 31, 2021 | -6.191M |
| March 31, 2020 | -3.007M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-11.83M
Minimum
Mar 2024
-3.007M
Maximum
Mar 2020
-7.737M
Average
-7.429M
Median
Net Income (Quarterly) Benchmarks
| Immuneering Corp | -14.31M |
| Outlook Therapeutics Inc | -114.29M |
| Amylyx Pharmaceuticals Inc | -118.79M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 10.24M |
| EPS Diluted (Quarterly) | -1.15 |
| Enterprise Value | 72.06M |
| Earnings Yield | -70.89% |